Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Fillable CY 2022 – 2026 CDC DHP and HRSA HAB Integrated Prevention and Care Plan Guidance Checklist
Checklist required in the submission of the Integrated Plans for 2022-2026.Resource updated 09/19/2023
-
Crosswalk of the Integrated HIV Prevention and Care Plan Guidance (CY 2016-2021 and CY 2022-2026) and the Ending the HIV Epidemic in the U.S. Program Guidance
Crosswalk of the required components of the 2022-2026 Integrated HIV Prevention and Care Plan with the 2016-2021 Integrated HIV Prevention and Care Plans and the EHE Planning Program Guidance.Resource updated 09/19/2023
-
HIV 101: Fundamentals of HIV Pathogenesis, Antiretroviral Therapy Initiation, & Primary Care for PWH
Session for clinicians new to the field of HIV or those looking for a review on the core principles of HIV management, including pathogenesis of HIV infection, mechanism of action of antiretroviral drugs, initiating antiretroviral therapy, and primary care for people with HIV.Resource (Conference Presentation) updated 09/14/2023
-
Addressing Implicit Bias Through Quality Improvement
Presentation on implicit bias and its impact on healthcare delivery.Resource updated 08/17/2023
-
Integrated HIV Prevention and Care Plan: Planning Requirements
Outline of the planning requirements for RWHAP Parts A and B recipients and all DHAP-funded state and local health departments as described in the Integrated HIV Prevention and Care Plan Guidance, Including the SCSN, CY 2022-2026.Resource updated 08/03/2023
-
Responsibilities and Expectations of Individual Members - How the PC/PB can Support Them
This resource for new planning council members helps orient them to their roles and duties as HIV community planners.Resource updated 04/18/2024
-
Innovative Intervention Strategies (2iS)
HRSA SPNS project applying the implementation science framework to identify innovative HIV interventions for three priority populations (people with substance use disorder, sexual minority youth, people involved in criminal justice system) and use of telehealth. Project period: 2021-2025.RWHAP Technical Assistance Provider updated on 04/02/2024
-
2021 Quality Award Winners Webinar
Winners of the CQII Quality of Care Awards in 2021, showcasing their work to assist Ryan White HIV/AIDS Program recipients in gaining insight into exemplary quality improvement and leadership efforts.Resource updated 08/17/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024
-
Integration of Oral Health and Primary Care in Seattle-King County
This referral-based oral health model used dental navigators to connect clients to a large network of dentists, which facilitated scheduling of appointments.Resource from the RWHAP Best Practices Compilation updated on 11/02/2023
-
Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Review of fact sheet on different coverage and cost-sharing considerations for LAI ART across public and private payers.Blog updated 12/22/2022
-
Make a Difference: How PC/PBs Can Strengthen The HIV System of Care
Overview of the HIV system of care and how PC/PBs can help strengthen it.Resource updated 01/05/2024
-
Chicago Area HIV Integrated Services Council
-
National Monitoring Standards and RWHAP Part B Manual Recipients
This HRSA technical assistance webinar provided a high level overview of updates made to both the National Monitoring Standards (NMS) and the Ryan White HIV/AIDS Program (RWHAP) Part B Manual. Release of the NMS is forthcoming.Resource updated 08/21/2023
-
Compendium of Evidence-informed Approaches to Improving Health Outcomes for People Living with HIV
Collection of implementation guides on evidence-informed best practices in HIV care delivery.Resource updated 03/04/2024
-
Buprenorphine Treatment for Opioid Use Disorder in HIV Primary Care: E2i
Buprenorphine Treatment for Opioid Use Disorder in HIV Primary Care is an integrated care approach designed to reduce opioid use and overdose while improving client engagement in HIV care. Greater Lawrence Family Health Center and Med Centro, Inc. implemented this integrated care approach as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients who participated in this intervention received integrated care—treatment for opioid use disorder (OUD) and HIV in a single setting—to improve retention in care, viral suppression, and engagement in OUD treatment.Resource from the RWHAP Best Practices Compilation updated on 01/03/2024